Full Press Release Details
Kyverna Therapeutics announces first publication of Ingenui-T, a novel CAR T-cell vein-to-vein manufacturing process.
KYTX
Kyverna Therapeutics announces first publication of Ingenui-T, a novel CAR T-cell vein-to-vein manufacturing process
Key Takeaway: Kyverna Therapeutics announces first publication of Ingenui-T, a novel CAR T-cell vein-to-vein manufacturing process